Ren et al. [10] showed that treatment of colonic mucosa from patients with ulcerative colitis (UC) with 100 nM Cl-IB-MECA for 24 h downregulated A3AR expression and upregulated TNF-α, NF-κB, and IL-1β production. This evidence concerns the gene ADORA3 and ulcerative colitis.